nodes	percent_of_prediction	percent_of_DWPC	metapath
Alosetron—CYP2C9—Ifosfamide—testicular cancer	0.136	0.233	CbGbCtD
Alosetron—CYP2E1—Etoposide—testicular cancer	0.125	0.214	CbGbCtD
Alosetron—CYP3A4—Ifosfamide—testicular cancer	0.0792	0.135	CbGbCtD
Alosetron—CYP1A2—Etoposide—testicular cancer	0.0723	0.124	CbGbCtD
Alosetron—CYP2C9—Cisplatin—testicular cancer	0.0663	0.113	CbGbCtD
Alosetron—CYP3A4—Vinblastine—testicular cancer	0.042	0.0719	CbGbCtD
Alosetron—CYP3A4—Etoposide—testicular cancer	0.0379	0.0647	CbGbCtD
Alosetron—CYP3A4—Doxorubicin—testicular cancer	0.0258	0.0442	CbGbCtD
Alosetron—Feeling abnormal—Chlorambucil—testicular cancer	0.00119	0.00286	CcSEcCtD
Alosetron—Alopecia—Ifosfamide—testicular cancer	0.00119	0.00286	CcSEcCtD
Alosetron—Ill-defined disorder—Dactinomycin—testicular cancer	0.00118	0.00285	CcSEcCtD
Alosetron—Abnormal dreams—Epirubicin—testicular cancer	0.00117	0.00282	CcSEcCtD
Alosetron—Myalgia—Bleomycin—testicular cancer	0.00116	0.0028	CcSEcCtD
Alosetron—Ulcer—Doxorubicin—testicular cancer	0.00116	0.00279	CcSEcCtD
Alosetron—Cystitis noninfective—Epirubicin—testicular cancer	0.00116	0.00278	CcSEcCtD
Alosetron—Jaundice—Etoposide—testicular cancer	0.00115	0.00277	CcSEcCtD
Alosetron—Discomfort—Bleomycin—testicular cancer	0.00115	0.00277	CcSEcCtD
Alosetron—Malaise—Dactinomycin—testicular cancer	0.00115	0.00277	CcSEcCtD
Alosetron—Urticaria—Chlorambucil—testicular cancer	0.00115	0.00276	CcSEcCtD
Alosetron—Bladder pain—Methotrexate—testicular cancer	0.00114	0.00275	CcSEcCtD
Alosetron—Urine output increased—Methotrexate—testicular cancer	0.00114	0.00275	CcSEcCtD
Alosetron—Bone pain—Doxorubicin—testicular cancer	0.00114	0.00275	CcSEcCtD
Alosetron—Cystitis—Epirubicin—testicular cancer	0.00114	0.00275	CcSEcCtD
Alosetron—Colitis—Epirubicin—testicular cancer	0.00114	0.00274	CcSEcCtD
Alosetron—Pain—Vinblastine—testicular cancer	0.00113	0.00272	CcSEcCtD
Alosetron—Constipation—Vinblastine—testicular cancer	0.00113	0.00272	CcSEcCtD
Alosetron—Confusional state—Bleomycin—testicular cancer	0.00113	0.00271	CcSEcCtD
Alosetron—Infection—Bleomycin—testicular cancer	0.00111	0.00267	CcSEcCtD
Alosetron—Feeling abnormal—Vinblastine—testicular cancer	0.00109	0.00262	CcSEcCtD
Alosetron—Myalgia—Dactinomycin—testicular cancer	0.00109	0.00261	CcSEcCtD
Alosetron—Ill-defined disorder—Ifosfamide—testicular cancer	0.00108	0.00261	CcSEcCtD
Alosetron—Abnormal dreams—Doxorubicin—testicular cancer	0.00108	0.00261	CcSEcCtD
Alosetron—Discomfort—Dactinomycin—testicular cancer	0.00107	0.00258	CcSEcCtD
Alosetron—Bladder pain—Epirubicin—testicular cancer	0.00107	0.00258	CcSEcCtD
Alosetron—Cystitis noninfective—Doxorubicin—testicular cancer	0.00107	0.00258	CcSEcCtD
Alosetron—Hypersensitivity—Chlorambucil—testicular cancer	0.00106	0.00256	CcSEcCtD
Alosetron—Cystitis—Doxorubicin—testicular cancer	0.00106	0.00255	CcSEcCtD
Alosetron—Hypoaesthesia—Etoposide—testicular cancer	0.00105	0.00254	CcSEcCtD
Alosetron—Malaise—Ifosfamide—testicular cancer	0.00105	0.00254	CcSEcCtD
Alosetron—Colitis—Doxorubicin—testicular cancer	0.00105	0.00253	CcSEcCtD
Alosetron—Polyuria—Methotrexate—testicular cancer	0.00105	0.00252	CcSEcCtD
Alosetron—Asthenia—Chlorambucil—testicular cancer	0.00103	0.00249	CcSEcCtD
Alosetron—Infection—Dactinomycin—testicular cancer	0.00103	0.00249	CcSEcCtD
Alosetron—Arrhythmia—Cisplatin—testicular cancer	0.00103	0.00249	CcSEcCtD
Alosetron—Alopecia—Cisplatin—testicular cancer	0.00102	0.00246	CcSEcCtD
Alosetron—Cough—Ifosfamide—testicular cancer	0.00102	0.00246	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.00102	0.00245	CcSEcCtD
Alosetron—Hypertension—Ifosfamide—testicular cancer	0.00101	0.00243	CcSEcCtD
Alosetron—Myalgia—Ifosfamide—testicular cancer	0.000995	0.0024	CcSEcCtD
Alosetron—Flatulence—Cisplatin—testicular cancer	0.000993	0.00239	CcSEcCtD
Alosetron—Bladder pain—Doxorubicin—testicular cancer	0.00099	0.00238	CcSEcCtD
Alosetron—Discomfort—Ifosfamide—testicular cancer	0.000983	0.00237	CcSEcCtD
Alosetron—Hypersensitivity—Vinblastine—testicular cancer	0.000973	0.00234	CcSEcCtD
Alosetron—Muscle spasms—Cisplatin—testicular cancer	0.000968	0.00233	CcSEcCtD
Alosetron—Confusional state—Ifosfamide—testicular cancer	0.000962	0.00232	CcSEcCtD
Alosetron—Eczema—Epirubicin—testicular cancer	0.000956	0.0023	CcSEcCtD
Alosetron—Pain—Bleomycin—testicular cancer	0.000954	0.0023	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.000948	0.00228	CcSEcCtD
Alosetron—Asthenia—Vinblastine—testicular cancer	0.000948	0.00228	CcSEcCtD
Alosetron—Infection—Ifosfamide—testicular cancer	0.000947	0.00228	CcSEcCtD
Alosetron—Tremor—Cisplatin—testicular cancer	0.000944	0.00227	CcSEcCtD
Alosetron—Alopecia—Etoposide—testicular cancer	0.000937	0.00226	CcSEcCtD
Alosetron—Ill-defined disorder—Cisplatin—testicular cancer	0.000935	0.00225	CcSEcCtD
Alosetron—Skin disorder—Ifosfamide—testicular cancer	0.000926	0.00223	CcSEcCtD
Alosetron—Hyperhidrosis—Ifosfamide—testicular cancer	0.000922	0.00222	CcSEcCtD
Alosetron—Feeling abnormal—Bleomycin—testicular cancer	0.000919	0.00221	CcSEcCtD
Alosetron—Vomiting—Chlorambucil—testicular cancer	0.000917	0.00221	CcSEcCtD
Alosetron—Malaise—Cisplatin—testicular cancer	0.000908	0.00219	CcSEcCtD
Alosetron—Fatigue—Dactinomycin—testicular cancer	0.000897	0.00216	CcSEcCtD
Alosetron—Pain—Dactinomycin—testicular cancer	0.00089	0.00214	CcSEcCtD
Alosetron—Muscle spasms—Etoposide—testicular cancer	0.000887	0.00214	CcSEcCtD
Alosetron—Urticaria—Bleomycin—testicular cancer	0.000886	0.00214	CcSEcCtD
Alosetron—Eczema—Doxorubicin—testicular cancer	0.000884	0.00213	CcSEcCtD
Alosetron—Hypoglycaemia—Epirubicin—testicular cancer	0.00088	0.00212	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000869	0.00209	CcSEcCtD
Alosetron—Myalgia—Cisplatin—testicular cancer	0.000858	0.00207	CcSEcCtD
Alosetron—Feeling abnormal—Dactinomycin—testicular cancer	0.000858	0.00207	CcSEcCtD
Alosetron—Nausea—Chlorambucil—testicular cancer	0.000856	0.00206	CcSEcCtD
Alosetron—Ill-defined disorder—Etoposide—testicular cancer	0.000856	0.00206	CcSEcCtD
Alosetron—Anxiety—Cisplatin—testicular cancer	0.000855	0.00206	CcSEcCtD
Alosetron—Discomfort—Cisplatin—testicular cancer	0.000847	0.00204	CcSEcCtD
Alosetron—Vomiting—Vinblastine—testicular cancer	0.00084	0.00202	CcSEcCtD
Alosetron—Malaise—Etoposide—testicular cancer	0.000832	0.002	CcSEcCtD
Alosetron—Headache—Vinblastine—testicular cancer	0.000828	0.00199	CcSEcCtD
Alosetron—Fatigue—Ifosfamide—testicular cancer	0.000822	0.00198	CcSEcCtD
Alosetron—Hypersensitivity—Bleomycin—testicular cancer	0.000822	0.00198	CcSEcCtD
Alosetron—Infection—Cisplatin—testicular cancer	0.000817	0.00197	CcSEcCtD
Alosetron—Pain—Ifosfamide—testicular cancer	0.000815	0.00196	CcSEcCtD
Alosetron—Constipation—Ifosfamide—testicular cancer	0.000815	0.00196	CcSEcCtD
Alosetron—Hypoglycaemia—Doxorubicin—testicular cancer	0.000814	0.00196	CcSEcCtD
Alosetron—Cough—Etoposide—testicular cancer	0.000805	0.00194	CcSEcCtD
Alosetron—Asthenia—Bleomycin—testicular cancer	0.000801	0.00193	CcSEcCtD
Alosetron—Skin disorder—Cisplatin—testicular cancer	0.000799	0.00192	CcSEcCtD
Alosetron—Hypertension—Etoposide—testicular cancer	0.000797	0.00192	CcSEcCtD
Alosetron—Hyperhidrosis—Cisplatin—testicular cancer	0.000795	0.00191	CcSEcCtD
Alosetron—Feeling abnormal—Ifosfamide—testicular cancer	0.000786	0.00189	CcSEcCtD
Alosetron—Nausea—Vinblastine—testicular cancer	0.000785	0.00189	CcSEcCtD
Alosetron—Abdominal pain upper—Epirubicin—testicular cancer	0.000785	0.00189	CcSEcCtD
Alosetron—Discomfort—Etoposide—testicular cancer	0.000776	0.00187	CcSEcCtD
Alosetron—Nasopharyngitis—Epirubicin—testicular cancer	0.000768	0.00185	CcSEcCtD
Alosetron—Hypersensitivity—Dactinomycin—testicular cancer	0.000767	0.00185	CcSEcCtD
Alosetron—Abdominal discomfort—Methotrexate—testicular cancer	0.000761	0.00183	CcSEcCtD
Alosetron—Gastritis—Epirubicin—testicular cancer	0.00076	0.00183	CcSEcCtD
Alosetron—Confusional state—Etoposide—testicular cancer	0.000759	0.00183	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Epirubicin—testicular cancer	0.000758	0.00182	CcSEcCtD
Alosetron—Urticaria—Ifosfamide—testicular cancer	0.000758	0.00182	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000749	0.0018	CcSEcCtD
Alosetron—Infection—Etoposide—testicular cancer	0.000748	0.0018	CcSEcCtD
Alosetron—Abdominal distension—Epirubicin—testicular cancer	0.000747	0.0018	CcSEcCtD
Alosetron—Asthenia—Dactinomycin—testicular cancer	0.000747	0.0018	CcSEcCtD
Alosetron—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000737	0.00178	CcSEcCtD
Alosetron—Skin disorder—Etoposide—testicular cancer	0.000732	0.00176	CcSEcCtD
Alosetron—Hyperhidrosis—Etoposide—testicular cancer	0.000728	0.00175	CcSEcCtD
Alosetron—Abdominal pain upper—Doxorubicin—testicular cancer	0.000726	0.00175	CcSEcCtD
Alosetron—Nasopharyngitis—Doxorubicin—testicular cancer	0.000711	0.00171	CcSEcCtD
Alosetron—Vomiting—Bleomycin—testicular cancer	0.000709	0.00171	CcSEcCtD
Alosetron—Depression—Methotrexate—testicular cancer	0.000705	0.0017	CcSEcCtD
Alosetron—Rash—Bleomycin—testicular cancer	0.000704	0.00169	CcSEcCtD
Alosetron—Gastritis—Doxorubicin—testicular cancer	0.000703	0.00169	CcSEcCtD
Alosetron—Pain—Cisplatin—testicular cancer	0.000703	0.00169	CcSEcCtD
Alosetron—Dermatitis—Bleomycin—testicular cancer	0.000703	0.00169	CcSEcCtD
Alosetron—Hypersensitivity—Ifosfamide—testicular cancer	0.000703	0.00169	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.000701	0.00169	CcSEcCtD
Alosetron—Abdominal distension—Doxorubicin—testicular cancer	0.000692	0.00167	CcSEcCtD
Alosetron—Upper respiratory tract infection—Epirubicin—testicular cancer	0.00069	0.00166	CcSEcCtD
Alosetron—Pollakiuria—Epirubicin—testicular cancer	0.000686	0.00165	CcSEcCtD
Alosetron—Asthenia—Ifosfamide—testicular cancer	0.000684	0.00165	CcSEcCtD
Alosetron—Sweating—Methotrexate—testicular cancer	0.000678	0.00163	CcSEcCtD
Alosetron—Feeling abnormal—Cisplatin—testicular cancer	0.000677	0.00163	CcSEcCtD
Alosetron—Hyperglycaemia—Epirubicin—testicular cancer	0.00067	0.00161	CcSEcCtD
Alosetron—Nausea—Bleomycin—testicular cancer	0.000663	0.0016	CcSEcCtD
Alosetron—Vomiting—Dactinomycin—testicular cancer	0.000662	0.00159	CcSEcCtD
Alosetron—Rash—Dactinomycin—testicular cancer	0.000656	0.00158	CcSEcCtD
Alosetron—Fatigue—Etoposide—testicular cancer	0.000649	0.00156	CcSEcCtD
Alosetron—Jaundice—Epirubicin—testicular cancer	0.000645	0.00155	CcSEcCtD
Alosetron—Pain—Etoposide—testicular cancer	0.000644	0.00155	CcSEcCtD
Alosetron—Constipation—Etoposide—testicular cancer	0.000644	0.00155	CcSEcCtD
Alosetron—Urinary tract infection—Epirubicin—testicular cancer	0.000643	0.00155	CcSEcCtD
Alosetron—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000638	0.00154	CcSEcCtD
Alosetron—Haemoglobin—Methotrexate—testicular cancer	0.000638	0.00154	CcSEcCtD
Alosetron—Haemorrhage—Methotrexate—testicular cancer	0.000635	0.00153	CcSEcCtD
Alosetron—Hepatitis—Methotrexate—testicular cancer	0.000635	0.00153	CcSEcCtD
Alosetron—Sweating—Epirubicin—testicular cancer	0.000635	0.00153	CcSEcCtD
Alosetron—Pollakiuria—Doxorubicin—testicular cancer	0.000635	0.00153	CcSEcCtD
Alosetron—Sinusitis—Epirubicin—testicular cancer	0.000621	0.0015	CcSEcCtD
Alosetron—Feeling abnormal—Etoposide—testicular cancer	0.000621	0.00149	CcSEcCtD
Alosetron—Hyperglycaemia—Doxorubicin—testicular cancer	0.00062	0.00149	CcSEcCtD
Alosetron—Nausea—Dactinomycin—testicular cancer	0.000618	0.00149	CcSEcCtD
Alosetron—Vomiting—Ifosfamide—testicular cancer	0.000606	0.00146	CcSEcCtD
Alosetron—Hypersensitivity—Cisplatin—testicular cancer	0.000606	0.00146	CcSEcCtD
Alosetron—Rash—Ifosfamide—testicular cancer	0.000601	0.00145	CcSEcCtD
Alosetron—Dermatitis—Ifosfamide—testicular cancer	0.000601	0.00145	CcSEcCtD
Alosetron—Urticaria—Etoposide—testicular cancer	0.000598	0.00144	CcSEcCtD
Alosetron—Haemoglobin—Epirubicin—testicular cancer	0.000597	0.00144	CcSEcCtD
Alosetron—Jaundice—Doxorubicin—testicular cancer	0.000597	0.00144	CcSEcCtD
Alosetron—Urinary tract infection—Doxorubicin—testicular cancer	0.000595	0.00143	CcSEcCtD
Alosetron—Hepatitis—Epirubicin—testicular cancer	0.000594	0.00143	CcSEcCtD
Alosetron—Haemorrhage—Epirubicin—testicular cancer	0.000594	0.00143	CcSEcCtD
Alosetron—Hypoaesthesia—Epirubicin—testicular cancer	0.000591	0.00142	CcSEcCtD
Alosetron—Asthenia—Cisplatin—testicular cancer	0.00059	0.00142	CcSEcCtD
Alosetron—Sweating—Doxorubicin—testicular cancer	0.000587	0.00141	CcSEcCtD
Alosetron—Sinusitis—Doxorubicin—testicular cancer	0.000575	0.00138	CcSEcCtD
Alosetron—Nausea—Ifosfamide—testicular cancer	0.000566	0.00136	CcSEcCtD
Alosetron—Alopecia—Methotrexate—testicular cancer	0.000561	0.00135	CcSEcCtD
Alosetron—Hypersensitivity—Etoposide—testicular cancer	0.000555	0.00134	CcSEcCtD
Alosetron—Haemoglobin—Doxorubicin—testicular cancer	0.000553	0.00133	CcSEcCtD
Alosetron—Haemorrhage—Doxorubicin—testicular cancer	0.00055	0.00132	CcSEcCtD
Alosetron—Hepatitis—Doxorubicin—testicular cancer	0.00055	0.00132	CcSEcCtD
Alosetron—Hypoaesthesia—Doxorubicin—testicular cancer	0.000547	0.00132	CcSEcCtD
Alosetron—Asthenia—Etoposide—testicular cancer	0.00054	0.0013	CcSEcCtD
Alosetron—Arrhythmia—Epirubicin—testicular cancer	0.000531	0.00128	CcSEcCtD
Alosetron—Alopecia—Epirubicin—testicular cancer	0.000525	0.00126	CcSEcCtD
Alosetron—Vomiting—Cisplatin—testicular cancer	0.000523	0.00126	CcSEcCtD
Alosetron—Rash—Cisplatin—testicular cancer	0.000518	0.00125	CcSEcCtD
Alosetron—Dermatitis—Cisplatin—testicular cancer	0.000518	0.00125	CcSEcCtD
Alosetron—Ill-defined disorder—Methotrexate—testicular cancer	0.000513	0.00124	CcSEcCtD
Alosetron—Flatulence—Epirubicin—testicular cancer	0.00051	0.00123	CcSEcCtD
Alosetron—Malaise—Methotrexate—testicular cancer	0.000498	0.0012	CcSEcCtD
Alosetron—Muscle spasms—Epirubicin—testicular cancer	0.000497	0.0012	CcSEcCtD
Alosetron—Arrhythmia—Doxorubicin—testicular cancer	0.000491	0.00118	CcSEcCtD
Alosetron—Nausea—Cisplatin—testicular cancer	0.000488	0.00118	CcSEcCtD
Alosetron—Alopecia—Doxorubicin—testicular cancer	0.000486	0.00117	CcSEcCtD
Alosetron—Cough—Methotrexate—testicular cancer	0.000482	0.00116	CcSEcCtD
Alosetron—Ill-defined disorder—Epirubicin—testicular cancer	0.00048	0.00116	CcSEcCtD
Alosetron—Vomiting—Etoposide—testicular cancer	0.000479	0.00115	CcSEcCtD
Alosetron—Rash—Etoposide—testicular cancer	0.000475	0.00114	CcSEcCtD
Alosetron—Dermatitis—Etoposide—testicular cancer	0.000474	0.00114	CcSEcCtD
Alosetron—Headache—Etoposide—testicular cancer	0.000472	0.00114	CcSEcCtD
Alosetron—Flatulence—Doxorubicin—testicular cancer	0.000472	0.00114	CcSEcCtD
Alosetron—Myalgia—Methotrexate—testicular cancer	0.000471	0.00113	CcSEcCtD
Alosetron—Malaise—Epirubicin—testicular cancer	0.000466	0.00112	CcSEcCtD
Alosetron—Discomfort—Methotrexate—testicular cancer	0.000465	0.00112	CcSEcCtD
Alosetron—Muscle spasms—Doxorubicin—testicular cancer	0.00046	0.00111	CcSEcCtD
Alosetron—Confusional state—Methotrexate—testicular cancer	0.000455	0.0011	CcSEcCtD
Alosetron—Cough—Epirubicin—testicular cancer	0.000451	0.00109	CcSEcCtD
Alosetron—Infection—Methotrexate—testicular cancer	0.000448	0.00108	CcSEcCtD
Alosetron—Nausea—Etoposide—testicular cancer	0.000447	0.00108	CcSEcCtD
Alosetron—Hypertension—Epirubicin—testicular cancer	0.000447	0.00108	CcSEcCtD
Alosetron—Ill-defined disorder—Doxorubicin—testicular cancer	0.000444	0.00107	CcSEcCtD
Alosetron—Myalgia—Epirubicin—testicular cancer	0.00044	0.00106	CcSEcCtD
Alosetron—Anxiety—Epirubicin—testicular cancer	0.000439	0.00106	CcSEcCtD
Alosetron—Skin disorder—Methotrexate—testicular cancer	0.000438	0.00106	CcSEcCtD
Alosetron—Hyperhidrosis—Methotrexate—testicular cancer	0.000436	0.00105	CcSEcCtD
Alosetron—Discomfort—Epirubicin—testicular cancer	0.000435	0.00105	CcSEcCtD
Alosetron—Malaise—Doxorubicin—testicular cancer	0.000432	0.00104	CcSEcCtD
Alosetron—Dry mouth—Epirubicin—testicular cancer	0.000431	0.00104	CcSEcCtD
Alosetron—Confusional state—Epirubicin—testicular cancer	0.000426	0.00103	CcSEcCtD
Alosetron—Infection—Epirubicin—testicular cancer	0.000419	0.00101	CcSEcCtD
Alosetron—Cough—Doxorubicin—testicular cancer	0.000418	0.00101	CcSEcCtD
Alosetron—Hypertension—Doxorubicin—testicular cancer	0.000413	0.000995	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000411	0.00099	CcSEcCtD
Alosetron—Skin disorder—Epirubicin—testicular cancer	0.00041	0.000988	CcSEcCtD
Alosetron—Hyperhidrosis—Epirubicin—testicular cancer	0.000408	0.000983	CcSEcCtD
Alosetron—Myalgia—Doxorubicin—testicular cancer	0.000407	0.000982	CcSEcCtD
Alosetron—Anxiety—Doxorubicin—testicular cancer	0.000406	0.000978	CcSEcCtD
Alosetron—Discomfort—Doxorubicin—testicular cancer	0.000403	0.00097	CcSEcCtD
Alosetron—Dry mouth—Doxorubicin—testicular cancer	0.000399	0.00096	CcSEcCtD
Alosetron—Confusional state—Doxorubicin—testicular cancer	0.000394	0.000949	CcSEcCtD
Alosetron—Fatigue—Methotrexate—testicular cancer	0.000389	0.000937	CcSEcCtD
Alosetron—Infection—Doxorubicin—testicular cancer	0.000388	0.000935	CcSEcCtD
Alosetron—Pain—Methotrexate—testicular cancer	0.000386	0.000929	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000385	0.000926	CcSEcCtD
Alosetron—Skin disorder—Doxorubicin—testicular cancer	0.000379	0.000914	CcSEcCtD
Alosetron—Hyperhidrosis—Doxorubicin—testicular cancer	0.000378	0.00091	CcSEcCtD
Alosetron—Feeling abnormal—Methotrexate—testicular cancer	0.000372	0.000895	CcSEcCtD
Alosetron—Fatigue—Epirubicin—testicular cancer	0.000364	0.000877	CcSEcCtD
Alosetron—Pain—Epirubicin—testicular cancer	0.000361	0.00087	CcSEcCtD
Alosetron—Constipation—Epirubicin—testicular cancer	0.000361	0.00087	CcSEcCtD
Alosetron—Urticaria—Methotrexate—testicular cancer	0.000358	0.000863	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000356	0.000857	CcSEcCtD
Alosetron—Feeling abnormal—Epirubicin—testicular cancer	0.000348	0.000838	CcSEcCtD
Alosetron—Fatigue—Doxorubicin—testicular cancer	0.000337	0.000811	CcSEcCtD
Alosetron—Urticaria—Epirubicin—testicular cancer	0.000335	0.000808	CcSEcCtD
Alosetron—Pain—Doxorubicin—testicular cancer	0.000334	0.000805	CcSEcCtD
Alosetron—Constipation—Doxorubicin—testicular cancer	0.000334	0.000805	CcSEcCtD
Alosetron—Hypersensitivity—Methotrexate—testicular cancer	0.000332	0.000801	CcSEcCtD
Alosetron—Asthenia—Methotrexate—testicular cancer	0.000324	0.00078	CcSEcCtD
Alosetron—Feeling abnormal—Doxorubicin—testicular cancer	0.000322	0.000775	CcSEcCtD
Alosetron—Hypersensitivity—Epirubicin—testicular cancer	0.000311	0.000749	CcSEcCtD
Alosetron—Urticaria—Doxorubicin—testicular cancer	0.00031	0.000747	CcSEcCtD
Alosetron—Asthenia—Epirubicin—testicular cancer	0.000303	0.00073	CcSEcCtD
Alosetron—Hypersensitivity—Doxorubicin—testicular cancer	0.000288	0.000693	CcSEcCtD
Alosetron—Vomiting—Methotrexate—testicular cancer	0.000287	0.000691	CcSEcCtD
Alosetron—Rash—Methotrexate—testicular cancer	0.000284	0.000685	CcSEcCtD
Alosetron—Dermatitis—Methotrexate—testicular cancer	0.000284	0.000685	CcSEcCtD
Alosetron—Headache—Methotrexate—testicular cancer	0.000283	0.000681	CcSEcCtD
Alosetron—Asthenia—Doxorubicin—testicular cancer	0.00028	0.000675	CcSEcCtD
Alosetron—Vomiting—Epirubicin—testicular cancer	0.000268	0.000647	CcSEcCtD
Alosetron—Nausea—Methotrexate—testicular cancer	0.000268	0.000645	CcSEcCtD
Alosetron—Rash—Epirubicin—testicular cancer	0.000266	0.000641	CcSEcCtD
Alosetron—Dermatitis—Epirubicin—testicular cancer	0.000266	0.000641	CcSEcCtD
Alosetron—Headache—Epirubicin—testicular cancer	0.000264	0.000637	CcSEcCtD
Alosetron—Nausea—Epirubicin—testicular cancer	0.000251	0.000604	CcSEcCtD
Alosetron—Vomiting—Doxorubicin—testicular cancer	0.000248	0.000598	CcSEcCtD
Alosetron—Rash—Doxorubicin—testicular cancer	0.000246	0.000593	CcSEcCtD
Alosetron—Dermatitis—Doxorubicin—testicular cancer	0.000246	0.000593	CcSEcCtD
Alosetron—Headache—Doxorubicin—testicular cancer	0.000245	0.000589	CcSEcCtD
Alosetron—Nausea—Doxorubicin—testicular cancer	0.000232	0.000559	CcSEcCtD
